Eargo Link vs Lexie B3

The Eargo Link is a mid-priced OTC hearing aid that earned an A grade with a SoundScore of 4.1/5 in our lab testing, placing it in the top 22% of the OTC hearing aid category. At $799, this visible-in-ear style device offers a balance of solid speech performance and exceptional streaming capabilities. In our testing, the Eargo Link demonstrated strong music streaming quality, scoring 2.48 points above the category average—a standout result for consumers who prioritize audio entertainment. Speech in quiet environments also performed well at 0.42 points above average, while speech in noise scored above the category average but remained mixed in absolute terms at 2.0/5. Feedback handling was excellent at 4.7/5. The most notable limitation is own-voice comfort, which scored 1.3/5—significantly below the category average by 1.21 points. Users sensitive to hearing their own voice may find this distracting, particularly with the closed dome configuration used in our tuned fit. The Eargo Link features rechargeable batteries and supports both iPhone and Android streaming with hands-free functionality. It's best suited for consumers who value premium streaming audio quality and solid speech clarity in quieter settings, and who can tolerate some own-voice compromise. Those prioritizing speech in noise or own-voice comfort may want to consider alternatives like the Sony CRE-E10 or Lexie B2 Plus in this price range.

The Lexie B3 is a mid-priced OTC hearing aid available at $999 that achieves an A grade with a SoundScore of 4.7/5 in our lab testing, ranking #1 among 65 OTC hearing aid devices tested. This behind-the-ear style device delivers category-leading performance across multiple metrics. Speech clarity is a standout strength. In our lab testing, the Lexie B3 scores an excellent 4.5/5 for speech in quiet, measuring 1.73 points above the OTC category average. Speech in noise performance scores 2.5/5—above the category average by 1.02 points, though only mixed in absolute terms at 2.5/5. This pattern reflects the broader challenge OTC devices face in noisy environments while still positioning the B3 as a top performer relative to its category. Music streaming quality is solid at 3.3/5, outperforming the category average by 1.38 points. Own-voice comfort scores a solid 3.0/5, sitting 0.49 points above average. Feedback handling is excellent at 4.6/5, essentially matching the already-strong category average. The Lexie B3 is best suited for consumers seeking top-tier OTC sound performance without prescription hearing aid costs. Those who prioritize speech clarity in quieter settings will find particular value here. Budget-conscious shoppers may want to consider alternatives like the RxEars Rxi, which offers strong performance at a lower price point.